29,987 views
22 patients treated in France, the United States, Thailand and Australia. Prof. Philippe Leboulch and his team at the François-Jacob Institute of the CEA have developed a gene therapy to definitively treat patients with beta-thalassemia, a genetic blood disease. Prof. Leboulch plans to launch it on the market in 2018, following the phase 3 trials currently underway. 0:00 What is beta-thalassemia? 1:17 Are there any curative treatments? 2:05 Clinical results of gene therapy 3:33 Secrets of this new therapy 5:33 Hopes for gene therapy ???? Don't forget to like, comment and subscribe to our channel: https://www.youtube.com/user/CEAscien...